Labocanna

Labocanna SG&A Expenses

The Selling, General & Administrative Expenses of Labocanna (LCN.WA) as of Oct 30, 2026 is 247,609.96 PLN. In the previous year, Selling, General & Administrative Expenses was 560,000.00 PLN — a change of -55.78% (lower).

SG&A Expenses

247,609.96PLN

YoY

-55.78%

Last updated:

Selling, General & Administrative Expenses of Labocanna is 2022 247,609.96 PLN. Selling, General & Administrative Expenses of Labocanna was 2021 560,000.00 PLN. It decreases by -55.78% lower compared to the previous year.

The Labocanna SG&A Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

SG&A Expenses
Date
SG&A Expenses
Jan 1, 2015
5.54 M PLN
Jan 1, 2016
5.56 M PLN
Jan 1, 2017
4.53 M PLN
Jan 1, 2018
3.12 M PLN
Jan 1, 2019
110,000.00 PLN
Jan 1, 2020
70,000.00 PLN
Jan 1, 2021
560,000.00 PLN
Jan 1, 2022
247,609.96 PLN
The Labocanna SG&A Expenses history
YEARSG&A ExpensesYoY
247,609.96PLN-55.78%
560,000.00PLN+700.00%
70,000.00PLN-36.36%
110,000.00PLN-96.47%
3.12 MPLN-31.13%
4.53 MPLN-18.53%
5.56 MPLN+0.36%
5.54 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Labocanna Stock analysis

What does Labocanna do? Labocanna SA is a pharmaceutical company based in Koszalin, Poland, operating within the Health Care sector. The company's primary focus is on the hemp business, as indicated by its operational description. It completed its initial public offering (IPO) on July 4, 2011, marking its entry into the public market. Labocanna SA is listed under the ticker symbol LCN.WA and holds the ISIN code PLCCTLS00017. The company's headquarters are located in Koszalin, a city in the West Pomeranian Voivodeship (Woj. Zachodniopomorskie) of Poland. Its official website is https://labocanna.pl/, which serves as a primary source of information about its operations and offerings. The company operates within the pharmaceutical industry, though specific details about its products, services, or market position are not provided in the available information. Labocanna SA's activities are centered around the hemp sector, which may include the development, production, or distribution of hemp-related products, though the exact nature of these activities remains unspecified. The company's public listing and headquarters location are key identifiers for its operational and financial profile. No additional details regarding founding year, key personnel, acquisitions, or financial figures are included in the provided data. Labocanna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labocanna stock

Selling, General & Administrative Expenses of Labocanna is 247,609.96 PLN in 2022.

Selling, General & Administrative Expenses of Labocanna changed from 560,000.00 PLN to 247,609.96 PLN, representing a -55.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Selling, General & Administrative Expenses Labocanna since 2006 – with annual values, charts, and detailed analysis.

SG&A expenses include all non-production costs such as salaries, marketing, rent, and administrative overhead. They are a key component of operating expenses.

Selling, General & Administrative Expenses's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Selling, General & Administrative Expenses's Labocanna historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Labocanna

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Labocanna